{
  "functional_evidence_assessment": [
    {
      "variant_id": {
        "Gene": "SNCA",
        "Protein_Change": {
          "ref": "A",
          "alt": "P",
          "position": "30"
        },
        "variant_string_id": "SNCA A30P"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "Both mutations produce the same effect.",
          "judgment": "Yes",
          "reasoning": "The paper indicates that both mutations (A30P and A53T) have the same effect, suggesting they are related to the disease mechanism."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "Used real time RT-PCR to analyze gene expression levels and validate microarray data.",
          "judgment": "Yes",
          "reasoning": "The study used gene expression assays which are relevant to understanding how these mutations affect cellular function in Parkinson's disease.",
          "next_step_or_outcome": "Proceed to Step 3"
        },
        {
          "step_name": "Step 3a: Basic Controls and Replicates",
          "extracted_paper_info": "Used wild type as controls and performed experiments with multiple cell lines from different initial transfections.",
          "judgment": "Yes",
          "reasoning": "The study included wild type controls and used multiple cell lines to minimize variability, indicating proper replication.",
          "next_step_or_outcome": "Proceed to Sub-step 3c"
        },
        {
          "step_name": "Step 3c: Variant Controls",
          "extracted_paper_info": "Compared results with wild type and used multiple clones for each mutation type.",
          "judgment": "Yes",
          "reasoning": "The study compared the mutations with wild type controls and used multiple clones for each mutation type.",
          "next_step_or_outcome": "Proceed to Step 4"
        },
        {
          "step_name": "Step 4a: Statistical Analyses",
          "extracted_paper_info": "No explicit statistical analyses mentioned for calculating OddsPath.",
          "judgment": "No",
          "reasoning": "The text does not mention specific statistical tests or calculations for OddsPath.",
          "next_step_or_outcome": "Proceed to Sub-step 4b"
        },
        {
          "step_name": "Step 4b: No OddsPath Calculation",
          "extracted_paper_info": "Used wild type as controls and analyzed seven clones over-expressing a-synuclein (2 • A30P, 2 • A53T, and 3 • wild type).",
          "judgment": "No",
          "reasoning": "The study used a limited number of controls (3 wild type) which is below the threshold of 11 needed for moderate strength evidence.",
          "next_step_or_outcome": "Proceed to Sub-step 4c"
        },
        {
          "step_name": "Step 4c: Correlate OddsPath",
          "extracted_paper_info": "No OddsPath value calculated or mentioned in the text.",
          "judgment": "N/A",
          "reasoning": "There is no information provided about OddsPath calculations for this variant.",
          "next_step_or_outcome": "Final assessment"
        }
      ],
      "final_evidence_strength": {
        "type": "Pathogenic",
        "strength": "PS3_supporting"
      },
      "overall_conclusion": "The functional evidence for SNCA A30P mutation is supporting for pathogenicity (PS3_supporting) based on gene expression assays showing functional impact compared to wild type controls, but lacks sufficient statistical analyses or a large enough set of controls to achieve higher strength classification."
    },
    {
      "variant_id": {
        "Gene": "SNCA",
        "Protein_Change": {
          "ref": "A",
          "alt": "T",
          "position": "53"
        },
        "variant_string_id": "SNCA A53T"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "Both mutations produce the same effect.",
          "judgment": "Yes",
          "reasoning": "The paper indicates that both mutations (A30P and A53T) have the same effect, suggesting they are related to the disease mechanism."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "Used real time RT-PCR to analyze gene expression levels and validate microarray data.",
          "judgment": "Yes",
          "reasoning": "The study used gene expression assays which are relevant to understanding how these mutations affect cellular function in Parkinson's disease.",
          "next_step_or_outcome": "Proceed to Step 3"
        },
        {
          "step_name": "Step 3a: Basic Controls and Replicates",
          "extracted_paper_info": "Used wild type as controls and performed experiments with multiple cell lines from different initial transfections.",
          "judgment": "Yes",
          "reasoning": "The study included wild type controls and used multiple cell lines to minimize variability, indicating proper replication.",
          "next_step_or_outcome": "Proceed to Sub-step 3c"
        },
        {
          "step_name": "Step 3c: Variant Controls",
          "extracted_paper_info": "Compared results with wild type and used multiple clones for each mutation type.",
          "judgment": "Yes",
          "reasoning": "The study compared the mutations with wild type controls and used multiple clones for each mutation type.",
          "next_step_or_outcome": "Proceed to Step 4"
        },
        {
          "step_name": "Step 4a: Statistical Analyses",
          "extracted_paper_info": "No explicit statistical analyses mentioned for calculating OddsPath.",
          "judgment": "No",
          "reasoning": "The text does not mention specific statistical tests or calculations for OddsPath.",
          "next_step_or_outcome": "Proceed to Sub-step 4b"
        },
        {
          "step_name": "Step 4b: No OddsPath Calculation",
          "extracted_paper_info": "Used wild type as controls and analyzed seven clones over-expressing a-synuclein (2 • A30P, 2 • A53T, and 3 • wild type).",
          "judgment": "No",
          "reasoning": "The study used a limited number of controls (3 wild type) which is below the threshold of 11 needed for moderate strength evidence.",
          "next_step_or_outcome": "Proceed to Sub-step 4c"
        },
        {
          "step_name": "Step 4c: Correlate OddsPath",
          "extracted_paper_info": "No OddsPath value calculated or mentioned in the text.",
          "judgment": "N/A",
          "reasoning": "There is no information provided about OddsPath calculations for this variant.",
          "next_step_or_outcome": "Final assessment"
        }
      ],
      "final_evidence_strength": {
        "type": "Pathogenic",
        "strength": "PS3_supporting"
      },
      "overall_conclusion": "The functional evidence for SNCA A53T mutation is supporting for pathogenicity (PS3_supporting) based on gene expression assays showing functional impact compared to wild type controls, but lacks sufficient statistical analyses or a large enough set of controls to achieve higher strength classification."
    }
  ]
}